Abaxis Inc  

(Public, NASDAQ:ABAX)   Watch this stock  
Find more results for ABAX
63.01
+0.72 (1.16%)
Apr 20 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 62.30 - 63.98
52 week 36.77 - 66.89
Open 62.48
Vol / Avg. 118,778.00/124,101.00
Mkt cap 1.40B
P/E 72.21
Div/yield 0.10/0.63
EPS 0.87
Shares 22.54M
Beta 0.83
Inst. own 107%
Apr 22, 2015
Q4 2015 Abaxis Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Mar 17, 2015
Abaxis Inc at Sidoti & Company Emerging Growth Research Institutional Investor Forum
Mar 4, 2015
Abaxis Inc at Raymond James Institutional Investors Conference
Jan 29, 2015
Q3 2015 Abaxis Inc Earnings Call
Jan 29, 2015
Q3 2015 Abaxis Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 9.89% 8.25%
Operating margin 15.39% 12.10%
EBITD margin - 16.42%
Return on average assets 9.79% 6.77%
Return on average equity 11.50% 7.67%
Employees 520 -
CDP Score - -

Address

3240 Whipple Road
UNION CITY, CA 94587
United States - Map
+1-510-6756500 (Phone)
+1-510-4416150 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Abaxis, Inc. (Abaxis) develops, manufactures, markets and sells portable blood analysis systems that are used in a range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. The Company provides veterinary reference laboratory diagnostic and consulting services for veterinarians. The Company operates in two segments, including the medical market and the veterinary market. The medical market and the veterinary market are based on the diagnostic products sold and services provided by market and customer group. The Company�s product and service offerings include VetScan Point-of-Care Blood Chemistry Instruments, VetScan Profiles, VSpro Specialty Analyzers and Consumables, and i-STAT Instruments and Consumables. Abaxis Europe GmbH, the Company�s wholly owned subsidiary in Griesheim, Germany, markets, promotes and distributes diagnostic systems for medical and veterinary uses in the European market.

Officers and directors

Clinton H. Severson Chairman of the Board, President, Chief Executive Officer
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Alberto R. Santa Ines Chief Financial Officer, Vice President - Finance
Age: 67
Bio & Compensation  - Reuters
Donald Peter Wood Chief Operations Officer
Age: 62
Bio & Compensation  - Reuters
Kenneth P. Aron Ph.D. Chief Technology Officer
Age: 61
Bio & Compensation  - Reuters
Ross Taylor Vice President - Business Development & Investor Relations
Bio & Compensation  - Reuters
Craig M. Tockman Vice President, Sales & Marketing � NAAH
Age: 54
Bio & Compensation  - Reuters
Achim Henkel Vice President - Marketing for Pacific Rim, Vice President - Government Affairs, Managing Director of Abaxis Europe GmbH
Age: 56
Bio & Compensation  - Reuters
Vernon Edward Altman Independent Director
Age: 67
Bio & Compensation  - Reuters
Richard J. Bastiani Ph.D. Independent Director
Age: 71
Bio & Compensation  - Reuters
Michael D. Casey Independent Director
Age: 68
Bio & Compensation  - Reuters